SLI
1.978,73
PKT
-31,89
PKT
-1,59
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.02.16 | Holcim Outperform | Credit Suisse Group | |
| 08.02.16 | Givaudan Hold | HSBC | |
| 08.02.16 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.16 | UBS Equal-Weight | Morgan Stanley | |
| 05.02.16 | UBS buy | Nomura | |
| 05.02.16 | UBS Neutral | UBS AG | |
| 05.02.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 04.02.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 04.02.16 | UBS Hold | S&P Capital IQ | |
| 04.02.16 | Holcim buy | Jefferies & Company Inc. | |
| 04.02.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 04.02.16 | Holcim buy | Kepler Cheuvreux | |
| 04.02.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 03.02.16 | UBS kaufen | Morgan Stanley | |
| 03.02.16 | Givaudan Hold | Kepler Cheuvreux | |
| 03.02.16 | Givaudan buy | Deutsche Bank AG | |
| 03.02.16 | Givaudan Outperform | BNP PARIBAS | |
| 03.02.16 | Richemont Outperform | BNP PARIBAS | |
| 03.02.16 | UBS Neutral | Nomura | |
| 03.02.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 03.02.16 | Givaudan overweight | JP Morgan Chase & Co. | |
| 02.02.16 | UBS buy | S&P Capital IQ | |
| 02.02.16 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 02.02.16 | Zurich Insurance kaufen | Baader Wertpapierhandelsbank | |
| 02.02.16 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.16 | Givaudan buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Swiss Re Equal weight | Barclays Capital | |
| 01.02.16 | Zurich Insurance overweight | Barclays Capital | |
| 01.02.16 | Roche buy | Société Générale Group S.A. (SG) | |
| 01.02.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 01.02.16 | UBS Underperform | BNP PARIBAS | |
| 01.02.16 | UBS Neutral | BNP PARIBAS | |
| 01.02.16 | Roche buy | UBS AG | |
| 01.02.16 | Roche buy | HSBC | |
| 01.02.16 | UBS Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.16 | UBS Neutral | Goldman Sachs Group Inc. | |
| 01.02.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.16 | Roche Outperform | Credit Suisse Group | |
| 29.01.16 | Roche Hold | S&P Capital IQ | |
| 29.01.16 | Roche overweight | JP Morgan Chase & Co. |